S5573 Disseminated Mycobacterium chelonae: A Rare Cause of Non-Caseating Granulomatous Hepatitis

Introduction: Granulomatous liver disease can have several etiologies, and non-caseating granulomas are commonly associated with sarcoidosis or autoimmune disease. We present a patient with respiratory symptoms and elevated liver enzymes who was found to have non-caseating granulomas on biopsy due to disseminated Mycobacterium chelonae. Case Description/Methods: A 68-year-old man with prior latent tuberculosis presented with a cough following viral respiratory infection. Computed tomography (CT) chest revealed a right lower lobe calcified granuloma. Liver enzymes were incidentally elevated with aspartate aminotransferase 97 IU/L, alanine aminotransferase 63 IU/L, alkaline phosphatase 387. Workup included negative hepatitis panel, HIV, and autoimmune serologies. He underwent a liver biopsy revealing nonspecific inflammation with non-necrotizing portal tract and lobular granulomata, concerning for granulomatous hepatitis. He was referred to Infectious Disease and underwent a full viral, parasitic, and fungal workup, including sputum culture, which was initially unrevealing. He was referred to a liver center for additional workup. Meanwhile, he underwent bronchoscopy with pulmonology but developed respiratory distress and hemodynamic instability post-procedure requiring intubation and admission. While hospitalized, his outpatient sputum cultures resulted with evidence of Mycobacterium chelonae. He started on intravenous imipenem, clarithromycin, and tobramycin for suspected disseminated Mycobacterium. Unfortunately, he had further deterioration from septic shock and respiratory failure and ultimately passed despite treatment. Discussion: Disseminated disease due to M. chelonae is rare, with approximately 100 cases reported. In our case, elevated liver enzymes were the first clue that led to further investigation and the identification of granulomatous hepatitis. Granulomatous hepatitis has a wide differential that includes infectious, autoimmune, and drug-induced causes. While mycobacterial infections are well-known etiologies, typically causing necrotizing granuloma, M. chelonae is rarely implicated. The absence of systemic signs at presentation, the subacute course, and presence of non-caseating granuloma further complicated this diagnosis. In this case, the identification of innumerable non-necrotizing granulomas on liver biopsy, despite negative acid-fast staining, prompted a thorough infectious evaluation, ultimately leading to the diagnosis. Early recognition and multidisciplinary evaluation are critical to diagnosis and management, although outcomes may remain poor despite therapy.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001149752.43653.cd
Primary Topic
Sarcoidosis and Beryllium Toxicity Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S5573 Disseminated Mycobacterium chelonae: A Rare Cause of Non-Caseating Granulomatous Hepatitis

Mark McGarrey, Julianna Tantum, Lauren Davis, Erin Hollis et al.
The American Journal of Gastroenterology
Sarcoidosis and Beryllium Toxicity Research
article

S5573 Disseminated Mycobacterium chelonae: A Rare Cause of Non-Caseating Granulomatous Hepatitis

Mark McGarrey, Julianna Tantum, Lauren Davis, Erin Hollis, Nicole Albert
article en

Abstract

Introduction: Granulomatous liver disease can have several etiologies, and non-caseating granulomas are commonly associated with sarcoidosis or autoimmune disease. We present a patient with respiratory symptoms and elevated liver enzymes who was found to have non-caseating granulomas on biopsy due to disseminated Mycobacterium chelonae. Case Description/Methods: A 68-year-old man with prior latent tuberculosis presented with a cough following viral respiratory infection. Computed tomography (CT) chest revealed a right lower lobe calcified granuloma. Liver enzymes were incidentally elevated with aspartate aminotransferase 97 IU/L, alanine aminotransferase 63 IU/L, alkaline phosphatase 387. Workup included negative hepatitis panel, HIV, and autoimmune serologies. He underwent a liver biopsy revealing nonspecific inflammation with non-necrotizing portal tract and lobular granulomata, concerning for granulomatous hepatitis. He was referred to Infectious Disease and underwent a full viral, parasitic, and fungal workup, including sputum culture, which was initially unrevealing. He was referred to a liver center for additional workup. Meanwhile, he underwent bronchoscopy with pulmonology but developed respiratory distress and hemodynamic instability post-procedure requiring intubation and admission. While hospitalized, his outpatient sputum cultures resulted with evidence of Mycobacterium chelonae. He started on intravenous imipenem, clarithromycin, and tobramycin for suspected disseminated Mycobacterium. Unfortunately, he had further deterioration from septic shock and respiratory failure and ultimately passed despite treatment. Discussion: Disseminated disease due to M. chelonae is rare, with approximately 100 cases reported. In our case, elevated liver enzymes were the first clue that led to further investigation and the identification of granulomatous hepatitis. Granulomatous hepatitis has a wide differential that includes infectious, autoimmune, and drug-induced causes. While mycobacterial infections are well-known etiologies, typically causing necrotizing granuloma, M. chelonae is rarely implicated. The absence of systemic signs at presentation, the subacute course, and presence of non-caseating granuloma further complicated this diagnosis. In this case, the identification of innumerable non-necrotizing granulomas on liver biopsy, despite negative acid-fast staining, prompted a thorough infectious evaluation, ultimately leading to the diagnosis. Early recognition and multidisciplinary evaluation are critical to diagnosis and management, although outcomes may remain poor despite therapy.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 51%
Sarcoidosis and Beryllium Toxicity Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.